These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38935988)

  • 1. APOE expression in papillary thyroid carcinoma: Influencing tumor progression and macrophage polarization.
    Huo R; Zhao R; Li Z; Li M; Bin Y; Wang D; Xue G; Wu J; Lin X
    Immunobiology; 2024 Sep; 229(5):152821. PubMed ID: 38935988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K/AKT signaling pathway.
    Lin X; Zhao R; Bin Y; Huo R; Xue G; Wu J
    Genomics; 2024 Sep; 116(5):110914. PubMed ID: 39128817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLHDC8A Regulates M1/M2 Macrophage Polarization Through the PD-1/STAT3 Pathway to Promote Papillary Thyroid Cancer Development.
    Peng Y; Wen M; Yu J; He C; Yu J
    Discov Med; 2024 Sep; 36(188):1858-1868. PubMed ID: 39327249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.
    Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W
    Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma.
    Le TN; Le MK; Dang MX; Kondo T
    Pathol Res Pract; 2024 Sep; 261():155474. PubMed ID: 39067172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis.
    Sun Z; Guo X; Zang M; Wang P; Xue S; Chen G
    J Cell Physiol; 2019 Feb; 234(2):1336-1345. PubMed ID: 30146756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer.
    Choi YS; Jeon MJ; Doolittle WKL; Song DE; Kim K; Kim WB; Kim WG
    Thyroid; 2024 Sep; 34(9):1150-1162. PubMed ID: 38666696
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma.
    Cho SW; Kim YA; Sun HJ; Kim YA; Oh BC; Yi KH; Park DJ; Park YJ
    Endocr Relat Cancer; 2016 Feb; 23(2):113-24. PubMed ID: 26559672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
    Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway.
    Guo W; Ren Y; Qiu X
    Sci Rep; 2024 Sep; 14(1):22574. PubMed ID: 39343799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
    Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
    Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
    Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.
    Chang WC; Chen JY; Lee CH; Yang AH
    Thyroid; 2013 Jun; 23(6):720-6. PubMed ID: 23186064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway.
    Sun Z; Zhang M; Ye Y; Yang L
    Horm Metab Res; 2024 May; 56(5):381-391. PubMed ID: 38286403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.